Vol 7 (February 28, 2023): Annals of Lymphoma

Original Article 
Is more better? Increased doses of high dose methotrexate and addition of rituximab is associated with improved outcomes in a large primary CNS lymphoma cohort
Prakirthi Yerram, Samantha N. Reiss, Lisa Modelevsky, Lauren Schaff, Anne S. Reiner, Katherine S. Panageas, Christian Grommes
Annals of Lymphoma  
2023;
7:
1  
(28 February 2023) 
PDF Full Text (1342) Reporting Checklist Data Sharing Statement COI Form Open Access Get Permission